Stryker invests about $400 million in surgical robot maker CMR Surgical

Stryker has put roughly $400 million into UK-based CMR Surgical and secured an exclusive option to buy the rest of the company. Under the deal, Stryker becomes the sole US sales agent for the Versius surgical robot range, while CMR keeps commercial control in other markets. The transaction still needs regulatory approval.

Summary written by DroidBazaar. The original article belongs to its publisher.